Reuben Kapur, Ph.D., Indiana University School of Medicine (IMAGE)
Caption
A drug now prescribed for cardiovascular problems could become a new tool in physicians' arsenals to attack certain types of leukemia that so far have evaded effective treatments, researchers say.
Credit
Indiana University
Usage Restrictions
None
License
Licensed content